News + Analysen
News + Adhoc
zugeh. Wertpapiere
Strukturierte Produkte
25.08.2019 23:00:00

3 Cancer Treatment Stocks to Buy Right Now

Cancer treatment is one of the hottest areas of healthcare investing these days, with personalized medicine like genetic therapies providing new promises of treatment and potential cures. Still, despite the progress that researchers have made, there are still plenty of false starts and treatments that don't end up delivering on the hopes their inventors and investors had for them.To cut through the clutter, we asked three Motley Fool contributors to pick a cancer treatment stock that looked worthy of investment. They selected Bristol-Myers Squibb (NYSE: BMY), Intuitive Surgical (NASDAQ: ISRG), and Myriad Genetics (NASDAQ: MYGN). Read on to find out why and to better inform your decision on whether these companies deserve a place in your portfolio.Image Source: Getty ImagesContinue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

Analysen zu NOW Inc When Issuedmehr Analysen

05.08.19 NOW Market Perform Cowen and Company, LLC
03.08.18 NOW Buy Stifel, Nicolaus & Co., Inc.
03.08.18 NOW Market Perform Cowen and Company, LLC
03.05.18 NOW Market Perform Cowen and Company, LLC
15.02.18 NOW Buy Stifel, Nicolaus & Co., Inc.

Eintrag hinzufügen

SMI auf Rekordkurs – Notenbanken im Fokus | BX Swiss TV

Aktien in diesem Artikel

Finanzen.net News